Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: A multicenter, double-blind, randomized study - 21/08/11
Nicholas Lowe, MD, University of California at Los Angeles School of Medicine, Santa Monica, CA, United States; Stephen Horwitz, MD, Miami Beach Dermatology Research Associates, Miami Beach, FL, United States; Emil Tanghetti, MD, University of California at Davis, Sacramento, CA, United States; Zoe Draelos, MD, Wake Forest University School of Medicine, Winston-Salem, NC, United States
Le texte complet de cet article est disponible en PDF. P222 Dr. Lowe has received research grants and consultancy payments from Allergan, Inc. and also owns stock in Allergan, Inc. Dr. Horwitz has no financial interests or relationships to declare. Dr. Tanghetti has received research grants and consultancy payments from Allergan, Inc. Dr. Draelos has received research grants from Allergan, Inc. Supported by Allergan, Inc. |
Vol 52 - N° 3S
P. P32 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?